Thousands to be monitored for safety of agitation inhaler
NCT ID NCT03513549
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tracks the safety of ADASUVE, an inhaled medication for calming agitation in people with schizophrenia or bipolar I disorder. Researchers will monitor up to 10,000 patients in real-world emergency or hospital settings to record any side effects. The goal is to better understand the drug's risks, not to test if it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION,PSYCHOMOTOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaceutical Research Associates, Inc
Raleigh, North Carolina, 27612, United States
Conditions
Explore the condition pages connected to this study.